Bausch Health Companies (BHC) Return on Capital Employed (2010 - 2026)
Bausch Health Companies (BHC) posted Return on Capital Employed of 4.39% for Q2 2026, up 56.41% sequentially from 2.81% in Q1 2026, and down 291.0% YoY from 2.3% in Q2 2025.
Bausch Health Companies (BHC) Return on Capital Employed (2010 - 2026) Analysis & Trends
Bausch Health Companies has reported Return on Capital Employed for 17 years, with the latest figure at 4.39% in Q2 2026.
- Quarterly Return on Capital Employed fell 291.0% year-over-year to 4.39% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 4.39% (down 291.0% YoY) and the FY2025 annual result came in at 8.14%, up 48.0% from the prior year.
- Return on Capital Employed advanced to 4.39% in Q2 2026 per BHC's latest filing, from 2.81% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 8.53% in Q3 2025 and troughed at 1.59% in Q1 2023.
- A 5-year average of 4.89% and a median of 4.6% in 2022 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2022 and 2026: Return on Capital Employed jumped 602 bps in 2022, then plunged 413 bps in 2026.
- Over 5 years, Return on Capital Employed stood at 2.06% in 2022, then jumped by 104 bps to 4.2% in 2023, then jumped by 86 bps to 7.82% in 2024, then increased by 3 bps to 8.09% in 2025, then plunged by 46 bps to 4.39% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 4.39%, 2.81%, and 8.09% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Bausch Health Companies | 2.57 Bn | 730.75 Mn | 2.10 Bn | 4.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.39% |
| Mar 31, 2026 | 2.81% |
| Dec 31, 2025 | 8.09% |
| Sep 30, 2025 | 8.53% |
| Jun 30, 2025 | 7.30% |
| Mar 31, 2025 | 6.94% |
| Dec 31, 2024 | 7.82% |
| Sep 30, 2024 | 6.13% |
| Jun 30, 2024 | 4.68% |
| Mar 31, 2024 | 4.70% |
| Dec 31, 2023 | 4.20% |
| Sep 30, 2023 | 1.65% |
| Jun 30, 2023 | 2.77% |
| Mar 31, 2023 | 1.59% |
| Dec 31, 2022 | 2.06% |
| Sep 30, 2022 | 4.52% |
| Jun 30, 2022 | 5.87% |
| Mar 31, 2022 | 3.92% |
| Dec 31, 2021 | 1.87% |
| Sep 30, 2021 | 0.32% |